Open access · CC-BY
via OpenAlex
MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors
Yuan‐Shuo Hsueh, Hui Hua Chang, Nai‐Jung Chiang, Chueh‐Chuan Yen, Chien‐Feng Li, Li‐Tzong Chen
Oncotarget · 2014 · ▲ 32 citations
Deregulated nutrient-sensing
Disabled macroautophagy
Rapamycin / mTOR inhibition
Cell culture / in vitro
Human
In vitro
Abstract
// Yuan-Shuo Hsueh 1 , Hui Hua Chang 2 , Nai-Jung Chiang 1,3 , Chueh-Chuan Yen 4,5 , Chien-Feng Li 1,6,7,8 and Li-Tzong Chen 1,2,3,9 1 National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan 2 Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan 3 Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan 4 Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 5 National Yang-Ming University School of Medicine, Taipei, Taiwan 6 Department of Pathology, Chi-Mei Foundation Medical Center, Tainan, Taiwan 7 Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan 8 Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan 9 Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwann Correspondence: Li-Tzong Chen, email: // Chien-Feng Li, email: // Keywords : gastrointestinal stromal tumor, KIT, heat shock protein 90 inhibitor, MTOR(definition) inhibitor, autophagy(definition) Received : June 19, 2014 Accepted : October 21, 2014 Published : October 21, 2014 Abstract Our previous study demonstrated NVP-AUY922, a HSP90AA1 inhibitor, could enhance mutant KIT degradation in gastrointestinal stromal tumor (GIST) cells through both proteasome- and autophagy-mediated pathways. Herein, we showed rapamycin(definition), a MTOR inhibitor and autophagy inducer, could reduce total and phospho-KIT expression levels and enhance apoptosis in imatinib-resistant GIST cells. The involvement of autophagy in rapamycin-induced KIT downregulation was further confirmed by co-localization of KIT and autophagosome, and partial recovery of KIT expression level by either siRNA-mediated BECN1 and ATG5 silencing or autophagy inhibitors after rapamycin. Rapamycin and NVP-AUY922 synergistically inhibited GIST cells growth in vitro . The combination of low-dose NVP-AUY922 with rapamycin had comparable effects on reducing KIT expression, increasing MAP1LC3B puncta and tumor necrosis, and inhibiting tumor growth as high-dose NVP-AUY922 did in GIST430 xenograft model. Our results suggest the addition of a MTOR inhibitor may reduce NVP-AUY922 dose requirement and potentially improve its therapeutic index in mutant KIT-expressing GISTs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/oncotarget.2607
- Canonical
- link ↗
- Fetched
- 2026-06-13 MST
Cite this
APA
Hsueh, Y., Chang, H.H., Chiang, N., Yen, C., Li, C., & Chen, L. (2014). MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors. <em>Oncotarget</em>. https://doi.org/10.18632/oncotarget.2607
Vancouver
Hsueh Y, Chang HH, Chiang N, Yen C, Li C, Chen L. MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors. Oncotarget. 2014. doi:10.18632/oncotarget.2607.
BibTeX
@article{yuanshuo2014MTORin,
title = {MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors},
author = {Yuan‐Shuo Hsueh and Hui Hua Chang and Nai‐Jung Chiang and Chueh‐Chuan Yen and Chien‐Feng Li and Li‐Tzong Chen},
journal = {Oncotarget},
year = {2014},
doi = {10.18632/oncotarget.2607},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Contemporary Clinical Trials 2022
Open access · OA
Time-restricted eating to improve cardiometabolic health: The New York Time-Restricted EATing randomized clinical trial – Protocol overview
Journal of the American Geriatrics Society 2021
Open access · OA
<scp>COVID</scp> ‐19 is not over and age is not enough: Using frailty for prognostication in hospitalized patients
European Journal of Immunology 2013
Open access · OA
The who's who of T ‐cell differentiation: Human memory T ‐cell subsets
Biomaterials 2024
Open access · CC-BY
Nanoparticle-mediated Klotho gene therapy prevents acute kidney injury to chronic kidney disease transition through regulating PPARα signaling in renal tubular epithelial cells
Stem Cells 2005
Citation only
Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells
Oncotarget 2016
Open access · CC-BY